| Trial name or title |
Prospective, randomized, double‐blind, placebo‐controlled study on parallel groups evaluating the efficacy and safety of cranberry (Vaccinium macrocarpon) in prevention of urinary tract infections in multiple sclerosis patients |
| Methods |
RCT |
| Participants |
Patients with multiple sclerosis |
| Interventions |
Dry essence of cranberry presented as 18 mg of PAC sachets of powdered cranberry. Cranberry juice is administered twice a day (in the morning and in the evening). |
| Outcomes |
Time to onset of a first UTI within one year of treatment |
| Starting date |
2006 |
| Contact information |
Philippe Gallien, http://clinicaltrials.gov/ct2/show/NCT00280592
|
| Notes |
Study completed February 2008: no publications |
